A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly.

Maria Fleseriu Zhaoyun Zhang K Hanman K Haria Aude Houchard Sheila Khawaja Antonio Ribeiro-Oliveira Junior Mônica Roberto Gadelha

Published in: Pituitary (2022)

Clinical efficacy/effectiveness, safety, and HRQoL outcomes in adults with acromegaly were similar and costs lower with EDIs versus standard regimens. Physicians may consider acromegaly treatment at EDIs, especially for patients with good disease control.

Keyphrases

growth hormone
primary care
randomized controlled trial
systematic review
type diabetes
metabolic syndrome
adipose tissue
replacement therapy
glycemic control